Free Trial

Protagenic Therapeutics (PTIX) SEC Filings & 10K Form

Protagenic Therapeutics logo
$0.56 +0.04 (+7.69%)
(As of 12/17/2024 ET)

Recent Protagenic Therapeutics SEC Filings

DateFilerForm TypeView
12/03/2024
6:20 AM
Protagenic Therapeutics, Inc.\new (Filer)
Protagenic Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2024
3:12 PM
Protagenic Therapeutics, Inc.\new (Filer)
Protagenic Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
4:19 PM
ARMISTICE CAPITAL, LLC (Filed by)
Protagenic Therapeutics, Inc.\new (Subject)
Protagenic Therapeutics (Subject)
Form SC 13G/A
11/05/2024
6:39 AM
Protagenic Therapeutics, Inc.\new (Filer)
Protagenic Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
8:52 PM
Protagenic Therapeutics, Inc.\new (Filer)
Protagenic Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2024
8:54 PM
Protagenic Therapeutics, Inc.\new (Filer)
Protagenic Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2024
4:30 PM
Protagenic Therapeutics, Inc.\new (Filer)
Protagenic Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
4:30 PM
Protagenic Therapeutics, Inc.\new (Filer)
Protagenic Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/22/2024
8:15 AM
Protagenic Therapeutics, Inc.\new (Filer)
Protagenic Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
3:33 PM
Protagenic Therapeutics, Inc.\new (Filer)
Protagenic Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2024
5:04 AM
Protagenic Therapeutics, Inc.\new (Filer)
Protagenic Therapeutics (Filer)
Form 10-K/A
04/23/2024
7:47 PM
Protagenic Therapeutics, Inc.\new (Filer)
Protagenic Therapeutics (Filer)
Form 10-K/A
04/01/2024
8:41 PM
Protagenic Therapeutics, Inc.\new (Issuer)
Protagenic Therapeutics (Issuer)
WRIGHT TIMOTHY R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
8:29 PM
Arrow Alexander K. (Reporting)
Protagenic Therapeutics, Inc.\new (Issuer)
Protagenic Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
8:29 PM
Corvese Brian (Reporting)
Protagenic Therapeutics, Inc.\new (Issuer)
Protagenic Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
8:29 PM
ARMEN GARO H (Reporting)
Protagenic Therapeutics, Inc.\new (Issuer)
Protagenic Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
8:29 PM
Buell Jennifer (Reporting)
Protagenic Therapeutics, Inc.\new (Issuer)
Protagenic Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
8:29 PM
Barrage Khalil (Reporting)
Protagenic Therapeutics, Inc.\new (Issuer)
Protagenic Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
8:29 PM
Protagenic Therapeutics, Inc.\new (Issuer)
Protagenic Therapeutics (Issuer)
Stein Robert Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
7:50 AM
Protagenic Therapeutics, Inc.\new (Filer)
Protagenic Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
1:29 PM
ARMISTICE CAPITAL, LLC (Filed by)
Protagenic Therapeutics, Inc.\new (Subject)
Protagenic Therapeutics (Subject)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:PTIX) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners